NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients
Clinical trial NCT04540406 · COMPLETED
Trial details
- NCT number
- NCT04540406
- Sponsor
- Notitia Biotechnologies Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-02
- Primary completion
- 2022-03-14
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.